Exela Pharma

Lenoir, United States Founded: 2005 • Age: 21 yrs
Sterile injectable pharmaceuticals are manufactured alongside CDMO services.
Request Access

About Exela Pharma

Exela Pharma is a company based in Lenoir (United States) founded in 2005 by Phanesh Koneru.. Exela Pharma has raised $7.09 million across 5 funding rounds from investors including Premier. The company has 247 employees as of December 31, 2019. Exela Pharma offers products and services including Sterile Injectables and CDMO Services.

  • Headquarter Lenoir, United States
  • Employees 247 as on 31 Dec, 2019
  • Founders Phanesh Koneru
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Exela Pharma Sciences Llc
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $7.09 M (USD)

    in 5 rounds

  • Latest Funding Round
  • Investors
  • Employee Count
    247

    as on Dec 31, 2019

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Exela Pharma

Exela Pharma offers a comprehensive portfolio of products and services, including Sterile Injectables and CDMO Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Develops and manufactures sterile injectables to address healthcare needs.

Provides R&D, manufacturing, and logistics for pharmaceutical clients.

People of Exela Pharma
Headcount 200-500
Employee Profiles 30
Employee Profiles
People
Mark Hartman
Chief Commercial Officer
People
Niasia Mcintyre
Project Manager
People
Yeng Vang
Senior Technology Transfer Specialist
People
Murthy Mallipeddi
Founder, Chief Scientific Officer

Unlock access to complete

Funding Insights of Exela Pharma

Exela Pharma has successfully raised a total of $7.09M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round
  • First Round

    (01 Jun 2008)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2021 Amount Series B - Exela Pharma Valuation

investors

Aug, 2015 Amount Private Equity Round - Exela Pharma Valuation

investors

Aug, 2015 Amount Series A - Exela Pharma Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Exela Pharma

Exela Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Premier. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Cloud-based practice management software is provided for organizations.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Exela Pharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Exela Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Exela Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Exela Pharma

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Exela Pharma

Frequently Asked Questions about Exela Pharma

When was Exela Pharma founded?

Exela Pharma was founded in 2005 and raised its 1st funding round 3 years after it was founded.

Where is Exela Pharma located?

Exela Pharma is headquartered in Lenoir, United States. It is registered at Lenoir, North Carolina, United States.

Who is the current CEO of Exela Pharma?

Phanesh Koneru is the current CEO of Exela Pharma. They have also founded this company.

Is Exela Pharma a funded company?

Exela Pharma is a funded company, having raised a total of $7.09M across 5 funding rounds to date. The company's 1st funding round was a Series A of $419.83K, raised on Jun 01, 2008.

How many employees does Exela Pharma have?

As of Dec 31, 2019, the latest employee count at Exela Pharma is 247.

What does Exela Pharma do?

Exela Pharma was founded in 2005 and is headquartered in Lenoir, United States, within the pharmaceutical sector. Proprietary and generic sterile injectables are developed and produced, covering the full lifecycle from research and development through manufacturing and distribution. Contract development and manufacturing services are offered for liquid vials, IV bags, lyophilized vials, and pre-filled syringes. Regulatory support is also provided to clients.

What products or services does Exela Pharma offer?

Exela Pharma offers Sterile Injectables and CDMO Services.

Who are Exela Pharma's investors?

Exela Pharma has 1 investor. Key investors include Premier.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available